UK and Singapore launch new regulatory corridor to speed up access to breakthrough health technologies

28 January 2026

On 12 December 2025, the Health Sciences Authority (“HSA”) announced the launch of a new regulatory innovation corridor by the UK and Singapore to speed up access to breakthrough health technologies. 

As part of this first-of-its-kind partnership between the UK’s Medicines and Healthcare products Regulatory Agency (“MHRA”) and HSA, companies will have a coordinated fast track pathway to engage both regulators at the same time. Under the new corridor, developers will be able to seek joint advice from both regulators early, helping them plan ahead and design better clinical trials, avoid duplication, and reduce delays. 

The aim is to speed up patient access to breakthrough therapies in high-impact areas such as cancer, dementia, obesity, rare diseases, and advanced diagnostics, without compromising on safety, while strengthening both countries’ position as global hubs for life science investment. 

The partnership builds on a long track record of UK-Singapore cooperation in science and technology. Together, MHRA and HSA will work more closely on early diagnosis, prevention, healthy ageing, and digital health, and supporting national strategies in both countries. 

The collaboration will be supported by joint work on AI in healthcare, with both regulators acting as the first two pioneer countries in the HealthAI Global Regulatory Network, and also draw on the UK’s National Commission into the Regulation of AI in Healthcare. HSA Chief Executive Adjunct Professor Dr Raymond Chua has joined the National Commission as a member. 

This new route forms part of wider efforts to unlock growth in UK life sciences and makes it simpler for global innovators to bring safe, effective medicines, and medical technologies to patients. It also builds on HSA’s ongoing efforts to strengthen Singapore’s position as a leading biotech hub, accelerate access to innovative health technologies, and set the pace in global regulatory innovation. 

Reference materials 

The press release is available on the HSA website www.hsa.gov.sg.